サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1650961

ゲル電気泳動の世界市場

Gel Electrophoresis

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.63円
ゲル電気泳動の世界市場
出版日: 2025年02月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

ゲル電気泳動の世界市場は2030年までに25億米ドルに到達

2024年に19億米ドルと推定されるゲル電気泳動の世界市場は、2024年から2030年にかけてCAGR 5.3%で成長し、2030年には25億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである研究室調査エンドユーズは、CAGR 5.3％を記録し、分析期間終了までに12億米ドルに達すると予測されます。製薬・バイオ企業エンドユーズ分野の成長率は、分析期間中CAGR 5.8%と推定されます。

米国市場は4億8,280万米ドルと推定、中国はCAGR8.2％で成長予測

米国のゲル電気泳動市場は、2024年には4億8,280万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.2%で推移し、2030年には5億7,520万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.1%と4.2%と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界のゲル電気泳動市場- 主要動向と促進要因のまとめ

ゲル電気泳動が現代の分子生物学および研究に不可欠な理由とは？

ゲル電気泳動は、分子生物学および生化学の基礎技術であり、核酸（DNA、RNA）およびタンパク質の分析と分離において重要な役割を果たしています。しかし、なぜこの技術が現代の科学研究において非常に重要なのでしょうか？ゲル電気泳動が不可欠なのは、科学者が分子の大きさ、電荷、形状に基づいて分子を分離し、遺伝物質やタンパク質を正確に可視化、定量、分析することを可能にするからです。この技術は、遺伝子指紋や法医学的分析から、遺伝子クローニング、遺伝子工学、タンパク質研究に至るまで、様々な用途で広く使用されています。

DNA分析において、ゲル電気泳動は、遺伝子研究や分子クローニングにおいて不可欠なステップであるポリメラーゼ連鎖反応（PCR）や制限酵素消化の成功を確認するために特に重要です。研究者はDNA断片の存在、サイズ、完全性を確認するためにこれを使用し、遺伝子のマッピング、遺伝子変異の研究、あるいは法医学事件における個人の同定を可能にします。タンパク質の研究においては、ゲル電気泳動はタンパク質の純度、分子量、構造の決定に役立ち、医薬品開発や診断アプリケーションに不可欠です。ゲル電気泳動は、その多用途性と精度の高さから、分子生物学研究の要であり続け、ゲノミクス、プロテオミクス、個別化医療における画期的な進歩を可能にしています。

技術の進歩はどのようにゲル電気泳動を強化しているのか？

ゲル電気泳動の技術的進歩は、その精度、スピード、使いやすさを大幅に向上させ、分子生物学および生化学研究のためのさらに強力なツールとなっています。主な技術革新の一つは、自動電気泳動システムの開発です。これらのシステムは、サンプルのロードからイメージングまで、電気泳動のすべてのステップを合理化された自動化されたプロセスに統合しています。自動化されたシステムは、人的ミスを減らし、一貫した結果を提供し、複数のサンプルを同時に分析することを可能にし、研究室のスループットと効率を向上させる。

もう一つの大きな進歩は、ゲル材料の改良です。伝統的なアガロースやポリアクリルアミドゲルは今でも広く使われているが、より優れた解像度と迅速なランタイムを持つ新しいゲルが開発されています。例えば、プレキャストゲルはあらかじめ調製されているので、研究者が自分でゲルを調製する必要がないです。プレキャストゲルはまた、厚さと組成がより均一で、より正確で再現性のある結果を保証します。さらに、密度の異なるグラジエント・ゲルの開発により、同一サンプル中の異なるサイズの分子をより正確に分離できるようになり、結果の透明性が向上しました。

蛍光染色技術は、ゲル電気泳動におけるもう一つのブレークスルーです。臭化エチジウムのような伝統的な染色は、より少量の核酸やタンパク質を検出できる、より安全で感度の高い蛍光色素に取って代わられました。これらの色素は目的の分子に結合し、特定の波長の光を照射すると明るい蛍光シグナルを発するので、微量の物質でも簡単に検出することができます。この感度は、正確な定量が不可欠な次世代シーケンシングやプロテオミクスのようなアプリケーションで特に価値があります。

さらに、電気泳動バッファーや温度制御システムなどの運転条件の進歩は、分離プロセス中の敏感な生体分子の劣化を防ぐのに役立ち、ゲル電気泳動の信頼性をさらに向上させています。このような技術革新により、ゲル電気泳動はより堅牢で、正確で、使いやすいものとなり、ゲノミクス、プロテオミクス、分子診断学などの最先端研究分野での利用が拡大しています。

なぜゲル電気泳動がDNA、RNA、タンパク質の調査・診断に不可欠なのか？

ゲル電気泳動は、DNA、RNA、タンパク質の分析、特に精度と正確さが最も重要視される研究・診断の現場で不可欠です。DNAやRNAの分析において、ゲル電気泳動は核酸をサイズ別に分離することができます。これは、PCRや制限酵素消化のような技術の後に、遺伝物質を可視化するために非常に重要です。この分離により、研究者は特定のDNAやRNA断片の存在を確認し、その品質を評価し、遺伝子マッピング、クローニング、配列決定における重要な要素であるサイズを決定することができます。法医学では、ゲル電気泳動はDNAフィンガープリントにも使用され、DNA断片のユニークなパターンを使って個人を特定したり、関係を確認したりすることができます。

タンパク質研究においては、ゲル電気泳動はタンパク質の組成、構造、機能を分析するために不可欠です。SDS-PAGE（Sodium Dodecyl Sulfate Polyacrylamideゲル電気泳動）のような技術では、タンパク質を分子量に基づいて分離することができ、科学者は複雑な混合物中の個々のタンパク質を研究することができます。これは、研究者が疾患経路に関与する特定のタンパク質を分離し、研究する必要がある医薬品開発には不可欠です。また、ゲル電気泳動はタンパク質の純度評価や翻訳後修飾の検出にも使用されます。これらは生化学研究や治療薬の開発において重要です。

さらに、ゲル電気泳動は遺伝子疾患、がん、感染症の診断に重要な役割を果たしています。例えば、嚢胞性線維症や鎌状赤血球貧血のような病気に関連する遺伝子の変異を同定するために一般的に使用されています。患者のサンプルからDNAやRNAを分離・分析することで、臨床医は特定の遺伝子異常を突き止めることができ、正確な診断と個人に合わせた治療計画が可能になります。さらに、ウェスタンブロッティングのような電気泳動ベースの技術は、自己免疫疾患における抗体や、HIVのような感染症におけるウイルス性タンパク質など、疾患に関連するタンパク質を検出するために臨床診断に用いられています。

要約すると、調査および診断の両分野で、生物学的分子を高い精度で分離し、分析する能力を提供する基本的なツールです。核酸やタンパク質を扱う際の汎用性と有効性により、遺伝学、疾病メカニズム、医薬品開発の理解を進める上で重要な技術となっています。

ゲル電気泳動市場の成長を促進する要因は？

ゲル電気泳動市場は、分子診断に対する需要の増加、ゲノム研究の進歩、より効率的で精密な検査技術へのニーズが相まって、力強い成長を遂げています。主な促進要因の一つは、DNA、RNA、タンパク質の分析に電気泳動を多用するゲノミクスとプロテオミクスの分野の拡大です。研究者が遺伝子発現調査、遺伝子マッピング、個別化医療を深く掘り下げるにつれて、ゲル電気泳動のような信頼性が高く正確な技術に対する需要は高まり続けています。

第二に、分子診断に対するニーズの高まりが市場の成長を後押ししています。遺伝性疾患、がん、感染症がますます蔓延する中、ヘルスケアプロバイダーはこれらの疾患を正確に特定し治療するために分子診断技術に注目しています。ゲル電気泳動は、遺伝子変異の検出、感染因子の特定、疾患の進行モニタリングなどの診断に一般的に使用されています。精密医療がヘルスケアにおける標準的なアプローチになるにつれ、正確なDNA、RNA、タンパク質分析の必要性が臨床現場における電気泳動技術の採用を後押ししています。

第三に、電気泳動システムの技術的進歩が、この技術をより身近に、より速く、より使いやすくしています。自動化されたゲル電気泳動システム、プレキャストゲル、高度なイメージング技術により、従来の電気泳動プロセスに必要な複雑さや時間が短縮され、この技術を採用する研究者や臨床医が増えています。これらの技術革新はまた、診断、医薬品開発、研究への応用に不可欠な結果の正確性と再現性を向上させています。

さらに、個別化医療やバイオマーカー探索への注目が高まっていることも、ゲル電気泳動市場の成長に寄与しています。研究者が疾患に関連する特定の遺伝子マーカーやタンパク質シグネチャーを特定しようとするとき、ゲル電気泳動はこれらの生体分子を分離・可視化するための重要な技術であり続けています。例えばがん研究では、電気泳動はタンパク質の発現パターンを調査し、潜在的な治療標的を特定するために使用され、高度な電気泳動システムの需要を牽引しています。

さらに、ライフサイエンス研究に対する政府の資金援助と投資が、市場の成長をさらに後押ししています。多くの国々がヘルスケアや研究イニシアチブの一環としてゲノム研究や分子診断に多額の投資を行っており、学術、臨床、製薬研究室でのゲル電気泳動技術の採用拡大につながっています。

結論として、ゲル電気泳動市場は、分子研究需要の高まり、診断技術の進歩、個別化医療の必要性、より高速で効率的な電気泳動システムの開発により成長しています。このような動向が続く中、ゲル電気泳動は研究室および臨床検査室における基幹技術であり続け、分子生物学への理解を深め、ヘルスケアの転帰を改善する上で重要な役割を果たすでしょう。

セグメント

エンドユーザー（ラボラトリーリサーチ、製薬&バイオテクノロジー企業、その他のエンドユーザー）

調査対象企業の例（全41件）

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • C.B.S. Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP12153

Global Gel Electrophoresis Market to Reach US$2.5 Billion by 2030

The global market for Gel Electrophoresis estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2024-2030. Laboratory Research End-Use, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Pharma & Biotech Companies End-Use segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$482.8 Million While China is Forecast to Grow at 8.2% CAGR

The Gel Electrophoresis market in the U.S. is estimated at US$482.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$575.2 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.1% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Gel Electrophoresis Market - Key Trends and Drivers Summarized

Why Is Gel Electrophoresis Critical in Modern Molecular Biology and Research?

Gel electrophoresis is a fundamental technique in molecular biology and biochemistry, playing a vital role in the analysis and separation of nucleic acids (DNA, RNA) and proteins. But why is this technique so crucial in modern scientific research? Gel electrophoresis is essential because it allows scientists to separate molecules based on their size, charge, or shape, making it possible to visualize, quantify, and analyze genetic material and proteins with precision. This technique is widely used in a range of applications, from genetic fingerprinting and forensic analysis to gene cloning, genetic engineering, and protein research.

In DNA analysis, gel electrophoresis is particularly important for verifying the success of polymerase chain reactions (PCR) or restriction enzyme digestion, which are essential steps in genetic studies and molecular cloning. Researchers use it to confirm the presence, size, and integrity of DNA fragments, enabling them to map genes, study genetic mutations, or even identify individuals in forensic cases. In protein studies, gel electrophoresis helps in determining the purity, molecular weight, and structure of proteins, making it indispensable for drug development and diagnostic applications. Given its versatility and precision, gel electrophoresis remains a cornerstone of molecular biology research, enabling breakthroughs in genomics, proteomics, and personalized medicine.

How Are Technological Advancements Enhancing Gel Electrophoresis?

Technological advancements in gel electrophoresis are significantly improving its precision, speed, and ease of use, making it an even more powerful tool for molecular and biochemical research. One of the key innovations is the development of automated electrophoresis systems. These systems integrate all the steps of electrophoresis—from sample loading to imaging—into a streamlined, automated process. Automated systems reduce human error, provide consistent results, and allow researchers to analyze multiple samples simultaneously, improving throughput and efficiency in laboratories.

Another major advancement is the improvement in gel materials. Traditional agarose and polyacrylamide gels are still widely used, but newer gels have been developed with better resolution and faster run times. For example, precast gels come pre-prepared, eliminating the need for researchers to prepare their own gels, which can be time-consuming and error-prone. Precast gels also offer more uniformity in thickness and composition, ensuring more accurate and reproducible results. Additionally, the development of gradient gels, which vary in density, allows for more precise separation of molecules of different sizes in the same sample, improving the clarity of results.

Fluorescent staining techniques represent another breakthrough in gel electrophoresis. Traditional stains like ethidium bromide have been largely replaced by safer and more sensitive fluorescent dyes that can detect much smaller quantities of nucleic acids and proteins. These dyes bind to the molecules of interest and, when exposed to specific wavelengths of light, produce a bright fluorescent signal, making it easier to detect even trace amounts of material. This sensitivity is particularly valuable in applications like next-generation sequencing or proteomics, where precise quantification is essential.

Additionally, advancements in electrophoresis buffers and running conditions, such as temperature-controlled systems, help prevent the degradation of sensitive biomolecules during the separation process, further improving the reliability of gel electrophoresis. These technological innovations are making gel electrophoresis more robust, accurate, and user-friendly, expanding its use in cutting-edge research fields such as genomics, proteomics, and molecular diagnostics.

Why Is Gel Electrophoresis Essential for DNA, RNA, and Protein Analysis in Research and Diagnostics?

Gel electrophoresis is indispensable for the analysis of DNA, RNA, and proteins, particularly in research and diagnostic settings where precision and accuracy are paramount. For DNA and RNA analysis, gel electrophoresis allows scientists to separate nucleic acids by size, which is crucial for visualizing genetic material after techniques like PCR or restriction enzyme digestion. This separation helps researchers confirm the presence of specific DNA or RNA fragments, assess their quality, and determine their size—key factors in gene mapping, cloning, and sequencing. In forensic science, gel electrophoresis is also used for DNA fingerprinting, where the unique patterns of DNA fragments can be used to identify individuals or verify relationships.

In protein research, gel electrophoresis is essential for analyzing protein composition, structure, and function. Techniques like SDS-PAGE (Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis) allow proteins to be separated based on their molecular weight, enabling scientists to study individual proteins in complex mixtures. This is critical for drug development, where researchers need to isolate and study specific proteins involved in disease pathways. Gel electrophoresis is also used to assess protein purity and to detect post-translational modifications, both of which are important in biochemical research and the development of therapeutics.

Moreover, gel electrophoresis plays a vital role in diagnosing genetic disorders, cancers, and infections. For example, it is commonly used to identify mutations in genes that are linked to diseases like cystic fibrosis or sickle cell anemia. By separating and analyzing DNA or RNA from patient samples, clinicians can pinpoint specific genetic abnormalities, allowing for accurate diagnosis and personalized treatment plans. Additionally, electrophoresis-based techniques like Western blotting are used in clinical diagnostics to detect proteins associated with diseases, such as antibodies in autoimmune disorders or viral proteins in infections like HIV.

In summary, gel electrophoresis is a fundamental tool in both research and diagnostics, providing the ability to separate and analyze biological molecules with a high degree of precision. Its versatility and effectiveness in handling nucleic acids and proteins make it a critical technique for advancing our understanding of genetics, disease mechanisms, and drug development.

What Factors Are Driving the Growth of the Gel Electrophoresis Market?

The gel electrophoresis market is experiencing strong growth, driven by a combination of increasing demand for molecular diagnostics, advancements in genomic research, and the need for more efficient and precise laboratory techniques. One of the primary drivers is the expanding field of genomics and proteomics, which relies heavily on electrophoresis for DNA, RNA, and protein analysis. As researchers delve deeper into gene expression studies, genetic mapping, and personalized medicine, the demand for reliable and accurate techniques like gel electrophoresis continues to rise.

Second, the growing need for molecular diagnostics is fueling market growth. With the increasing prevalence of genetic disorders, cancers, and infectious diseases, healthcare providers are turning to molecular diagnostic techniques to accurately identify and treat these conditions. Gel electrophoresis is commonly used in diagnostics to detect genetic mutations, identify infectious agents, and monitor the progression of diseases. As precision medicine becomes a standard approach in healthcare, the need for accurate DNA, RNA, and protein analysis is driving the adoption of electrophoresis technologies in clinical settings.

Third, technological advancements in electrophoresis systems are making the technique more accessible, faster, and easier to use. Automated gel electrophoresis systems, pre-cast gels, and advanced imaging techniques are reducing the complexity and time required for traditional electrophoresis processes, attracting more researchers and clinicians to adopt this technology. These innovations are also improving the accuracy and reproducibility of results, which is essential for applications in diagnostics, drug development, and research.

Additionally, the increasing focus on personalized medicine and biomarker discovery is contributing to the growth of the gel electrophoresis market. As researchers seek to identify specific genetic markers or protein signatures linked to diseases, gel electrophoresis remains a key technique for separating and visualizing these biomolecules. In cancer research, for example, electrophoresis is used to study protein expression patterns and identify potential therapeutic targets, driving the demand for advanced electrophoresis systems.

Moreover, government funding and investments in life science research are further propelling market growth. Many countries are investing heavily in genomics research and molecular diagnostics as part of their healthcare and research initiatives, leading to greater adoption of gel electrophoresis technologies in academic, clinical, and pharmaceutical laboratories.

In conclusion, the gel electrophoresis market is growing due to the rising demand for molecular research, advancements in diagnostic technologies, the need for personalized medicine, and the development of faster, more efficient electrophoresis systems. As these trends continue, gel electrophoresis will remain a cornerstone technique in both research and clinical laboratories, playing a critical role in advancing our understanding of molecular biology and improving healthcare outcomes.

SCOPE OF STUDY:

The report analyzes the Gel Electrophoresis market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Laboratory Research, Pharma & Biotech Companies, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • C.B.S. Scientific Company
  • GE Healthcare
  • Harvard Bioscience, Inc.
  • Helena Laboratories Corporation
  • Hoefer, Inc.
  • Lonza Group AG
  • MilliporeSigma
  • PerkinElmer, Inc.
  • SCIEX
  • Sebia SA
  • SERVA Electrophoresis GmbH
  • Shimadzu Corporation
  • Sysmex Partec GmbH
  • Takara Bio, Inc.
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Gel Electrophoresis - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Use of Gel Electrophoresis in Genomics and Proteomics Drives Market Growth
    • Role of Gel Electrophoresis in Drug Discovery and Development Processes
    • Market Opportunities in Emerging Biotechnology Markets
    • Consumer Demand for Faster, More Accurate Diagnostic Techniques
    • Advances in Microfluidics and Miniaturization of Electrophoresis Equipment
    • Environmental and Safety Considerations in Electrophoresis Media Disposal
    • Role of Gel Electrophoresis in Quality Control in Food and Beverage Industry
    • Future Trends: Towards Chip-based Electrophoresis and Lab-on-a-Chip Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Gel Electrophoresis Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Gel Electrophoresis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Laboratory Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Laboratory Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Gel Electrophoresis by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Gel Electrophoresis by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Gel Electrophoresis by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Gel Electrophoresis by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Gel Electrophoresis by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Gel Electrophoresis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Gel Electrophoresis by End-Use - Laboratory Research, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Gel Electrophoresis by End-Use - Percentage Breakdown of Value Sales for Laboratory Research, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION